文献速递胸部神经CT

CT上支气管血管束增厚可预测IA期周围型小细胞肺癌患者的生存和脑转移

Bronchovascular bundle thickening on CT as a predictor of survival and brain metastasis in patients with stage IA peripheral small cell lung cancer.
PubMed 文献 · Clin Radiol · 2020-09-16

回顾性分析79例≤3cm周围型小细胞肺癌术前CT,43%存在支气管血管束增厚,该征象在纵隔淋巴结转移和远处转移患者中更常见。IA期患者中无支气管血管束增厚者无进展生存、总生存和脑转移无生存均更优。多因素分析显示无支气管血管束增厚和手术是无进展生存的独立预后因素。

要点

  • ≤3cm周围型小细胞肺癌中支气管血管束增厚发生率为43%。
  • 支气管血管束增厚与纵隔淋巴结转移和远处转移相关。
  • IA期无支气管血管束增厚者无进展生存、总生存和脑转移无生存更优。

关键影像表现/征象

  • 支气管血管束增厚在纵隔淋巴结转移患者中占50.9%,无纵隔淋巴结转移者占22.7%(p=0.024)。
  • 支气管血管束增厚在远处转移患者中占60.9%,无远处转移者占35.7%(p=0.049)。

诊断标准与关键数值

  • 21例IA期患者中,16例(76.2%)无支气管血管束增厚者无进展生存平均1762天 vs 有增厚者483天(p=0.019)。
  • IA期无支气管血管束增厚者总生存平均2243天 vs 有增厚者1328天(p=0.038)。
  • IA期无支气管血管束增厚者脑转移无生存平均2274天 vs 有增厚者1287天(p=0.038)。
  • 多因素Cox回归显示无支气管血管束增厚(HR 7.806;95%CI 1.241-49.091;p=0.029)和手术(HR 0.075;95%CI 0.008-0.746;p=0.027)是无进展生存的独立预后因素。

临床应用与阅片要点

  • 阅片时注意评估≤3cm周围型小细胞肺癌是否伴有支气管血管束增厚,该征象与纵隔淋巴结转移和远处转移相关。
  • IA期周围型小细胞肺癌无支气管血管束增厚者无进展生存、总生存和脑转移无生存更优。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To determine if bronchovascular bundle (BVB) thickening on pretreatment computed tomography (CT) images helps predict survival in patients with peripheral small cell lung cancer (pSCLC) ≤3 cm.

MATERIALS AND METHODS: The pretreatment CT examinations of 79 histopathologically proven pSCLC ≤3 cm (TNM stage I, 21; II, 13; III, 22; IV, 23) were reviewed retrospectively. The CT characteristics of the nodule and associated findings, including BVB thickening, were evaluated. Progression-free survival (PFS), overall survival (OS), and brain metastasis-free survival were compared with the presence of BVB thickening using Kaplan-Meier and Cox regression analysis.

RESULTS: Among the 79 patients, 34 (43%) had BVB thickening. BVB thickening was prevalent in patients with mediastinal lymph node metastasis (50.9% versus 22.7%; p=0.024) and distant metastasis (60.9% versus 35.7%; p=0.049). Out of the 21 patients with TNM stage IA disease, the 16 patients (76.2%) without BVB thickening showed better PFS, OS, and brain metastasis-free survival (mean, 1,762 versus 483 days; p=0.019: 2,243 versus 1,328 days; p=0.038: 2,274 versus 1,287 days; p=0.038, respectively). Multivariate Cox regression analysis showed that the absence of BVB thickening (hazard ratio [HR], 7.806; 95% CI, 1.241-49.091; p=0.029) and surgery (HR, 0.075; 95% CI, 0.008-0.746; p=0.027) were independent and useful prognostic factors for PFS.

CONCLUSIONS: BVB thickening was found more frequently in patients with advanced-stage pSCLC ≤3 cm, and the PFS was more favourable in patients without BVB thickening, with a similar tendency to that of OS and brain metastasis-free survival, in stage IA pSCLC.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Sung P, Yoon SH, Kim J, et al. Bronchovascular bundle thickening on CT as a predictor of survival and brain metastasis in patients with stage IA peripheral small cell lung cancer. Clin Radiol. 2020. PMID: 32948314. doi:10.1016/j.crad.2020.08.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。